Silver Book Fact

According to the Pharmaceutical Research and Manufacturers of America, a medicine in development targets late-stage metastatic melanoma. The medicine contains a gene encoding antigen that may be able to alert the immune system when there is a foreign tissue present. This would in turn induce a powerful immune response.

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • The 1-year survival rate for lung cancer has increased from 37% in 1975 to 42% in 1999-2001, largely because of improvements to surgical techniques and with combined therapies.  
  • Studies have shown that annual mammograms reduce breast cancer related mortality in women by 20-40%.  
  • Increase in 5-year survival rate for cancer
     
  • Every additional dollar spent on newer, less toxic hormonal therapy for breast cancer patients has produced health gains valued at between $27.03 and $36.81.  
  • After one year, 73 percent of non-small-cell lung cancer patients with the EGFR genetic mutation who were treated with a tyrosine kinase inhibitor had survived, compared to 15 percent who…